Prevention of menstrual migraine with perimenstrual transdermal 17-β-estradiol: a randomized, placebo-controlled, double-blind crossover studyVisa övriga samt affilieringar
2011 (Engelska)Ingår i: Fertility and Sterility, ISSN 0015-0282, E-ISSN 1556-5653, Vol. 96, nr 2, s. 498-500.e1Artikel i tidskrift, Editorial material (Övrigt vetenskapligt) Published
Abstract [en]
The effect of treatment with percutaneous estradiol (100µg estradiol/24h) during two weeks perimenstrually on the number and severity of menstrual migraine attacks was studied in 27 women in a randomized, placebo-controlled double blind cross over trial. We were not able to demonstrate any difference between estradiol supplementation and placebo on the number or severity of migraine attacks but both regimens showed significant effects compared to pretreatment.
Ort, förlag, år, upplaga, sidor
Elsevier, 2011. Vol. 96, nr 2, s. 498-500.e1
Nyckelord [en]
menstrual migraine, estradiol, RCT
Nationell ämneskategori
Gynekologi, obstetrik och reproduktionsmedicin
Identifikatorer
URN: urn:nbn:se:oru:diva-107890DOI: 10.1016/j.fertnstert.2011.05.089ISI: 000293008700072PubMedID: 21704313Scopus ID: 2-s2.0-79960631558OAI: oai:DiVA.org:oru-107890DiVA, id: diva2:1792276
2023-08-292023-08-292025-02-11Bibliografiskt granskad